Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)PALMIERI, G; MEROLA, G; DEL PRETE, S et al.Annals of oncology. 2010, Vol 21, Num 6, pp 1168-1172, issn 0923-7534, 5 p.Article

Gemcitabine and Vinorelbine in Pemetrexed-Pretreated Patients With Malignant Pleural MesotheliomaZUCALI, Paolo A; CERESOLI, Giovanni L; GARASSINO, Isabella et al.Cancer. 2008, Vol 112, Num 7, pp 1555-1561, issn 0008-543X, 7 p.Article

Pemetrexed Versus Erlotinib in Pretreated Patients With Advanced Non-Small Cell Lung Cancer: A Hellenic Oncology Research Group (HORG) Randomized Phase 3 StudyKARAMPEAZIS, Athanasios; VOUTSINA, Alexandra; AGELAKI, Sofia et al.Cancer. 2013, Vol 119, Num 15, pp 2754-2764, issn 0008-543X, 11 p.Article

Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphomaTANI, Menica; MARIAPAOLA FINA, A; ALINARI, Lapo et al.Haematologica (Roma). 2005, Vol 90, Num 9, pp 1283-1284, issn 0390-6078, 2 p.Article

Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesotheliomaZUCALI, P. A; PERRINO, M; LORENZI, E et al.Lung cancer. 2014, Vol 84, Num 3, pp 265-270, issn 0169-5002, 6 p.Article

Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patientsBUONERBA, Carlo; FEDERICO, Piera; DI LORENZO, Giuseppe et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 6, pp 1455-1461, issn 0344-5704, 7 p.Article

Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II studyPECTASIDES, D; PECTASIDES, M; FARMAKIS, D et al.Annals of oncology. 2004, Vol 15, Num 3, pp 493-497, issn 0923-7534, 5 p.Article